(1) Whether the Medicines Control Council intends introducing a grandfather clause with regard to the registration of any medication; if so, (a) what type of medication, (b) how many products will be affected, (c) what are the reasons for the grandfather clause and (d) when will it come into effect; (2) what are the legal consequences for his department if medicines registered using the grandfather clause do not meet (a) quality, (b) safety and (c) efficacy standards?